3Kim HJ;Cho HK;Kwon YH.Synergistic induction of ER stress by homocysteine and beta-amyloid in SH-SY5Y cells[J]Journal of Nutritional Biochemistry,2008(11):754-761.
4Pahl HL.Signal transduction from the endoplasmic reticulum to the cell nucleus[J]Physiological Reviews,1999(03):683-701.
5Pahl HL;Baeuerle PA.A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B[J]EMBO Journal,1995(11):2580-2588.
6Brown MS;Goldstein JL.The SREBP pathway:regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor[J]CELL,1997(03):331-340.
7Glembotski CC.The role of the unfolded protein response in the heart[J]Journal of Molecular and Cellular Cardiology,2008(03):453-459.
9Dhalla NS;Saini-Chohan HK;Rodriguez-Leyva D.Subcellular remodelling may induce cardiac dysfunction in congestive heart failure[J]Cardiovascular Research,2009(03):429-438.
10Peng X;Wu X;Druso JE.Cardiac developmental defects and eccentric right ventricular hypertrophy in cardiomyocyte focal adhesion kinase (FAK) conditional knockout mice[J]Proceedings of the National Academy of Sciences(USA),2008(18):6638-6643.
8Krauser DG, Devereux RB. Ventricular hypertrophy and hypertension: prognostic elements and implications for management. Herz 2006; 31: 305-316.
9Pahl HL. Signal transduction from the endoplasmic reticulum to the cell nucleus. Physiol Rev 1999; 79(3): 683-701.
10Pahl HL, Baeuerle PA. A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B. EMBO J 1995; 14(11): 2580-2588.
5Bergelson JM, Modlin JF, Wieland-Alter W, et al. Clinicalcoxsackievirus B isolates differ from laboratory strains in theirinteraction with two cell surface receptors [ J ] . J Infect Dis,1997, 175(3) : 697-700.
6HequetO, LeQH, Moullct I, et a.l Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults. J Clin Oncol, 2004, 22(10): 1864-1871.
7Lipshultz SE, Lipsitz SR, Sallan SE, et a.l Chronic progressivecardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol, 2005, 23(12):2629-2636.
8Montani D,Chaumais MC, Guignabert C, et al. Targeted ther-apies in pulmonary arterial hypertension [J]. Pharmacol Ther, 2014,141(2) : 172-191.
9Lai YC, Potoka KC, Champion HC, et al. Pulmonary arterial hypertension: the clinical syndrome [J]. Circ Res,2014, 115 (1):115-130.
10van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventrieular mass,volume,and function in idiopathic pulmonary arterial hypertension [J]. Eur Heart J, 2007,28(10) : 1250-1257.
